2,3-DIHYDROISOINDOLE-1-CARBOXAMIDES USEFUL AS ROR-GAMMA MODULATORS

The present specification provides a compound of formula (I):or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an RORγ and/or RORγt mediated disease state.

Saved in:
Bibliographic Details
Main Authors OLSSON, Roine Ingemar, NARJES, Frank, VON BERG, Stefan, LEVER, Sarah
Format Patent
LanguageEnglish
Published 09.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present specification provides a compound of formula (I):or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an RORγ and/or RORγt mediated disease state.
Bibliography:Application Number: US202117314256